Combined Holdings of GH in All ARK ETFs
Guardant Health
GH, or Guardant Health, specializes in precision oncology through liquid biopsy technologies, which assist in the detection and management of cancer by analyzing DNA fragments from tumors found in blood samples. The company generates revenue primarily by providing these advanced diagnostic tests to healthcare providers, pharmaceutical companies, and research organizations, enabling them to make informed clinical decisions and develop personalized treatment plans.
Trades of GH in All Ark ETFs
The ten most recent trades of Guardant Health in all the Ark ETFs ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Nov 18, 2024 | Buy | $557,890 | 1.35% | 0.05% |
| Nov 15, 2024 | Buy | $990,703 | 2.40% | 0.08% |
| Nov 12, 2024 | Buy | $147,197 | 0.36% | 0.01% |
| Nov 11, 2024 | Buy | $1,551,567 | 4.02% | 0.12% |
| Nov 08, 2024 | Buy | $342,642 | 0.90% | 0.03% |
| Sep 17, 2024 | Buy | $1,328,604 | 4.18% | 0.10% |
| Sep 11, 2024 | Buy | $1,119,905 | 3.63% | 0.08% |
| Aug 26, 2024 | Buy | $771,011 | 2.45% | 0.05% |
| Aug 13, 2024 | Buy | $1,030,001 | 2.92% | 0.08% |
| Aug 09, 2024 | Buy | $765,895 | 2.29% | 0.06% |